What should be the core outcomes in chronic pain clinical trials?

AUTOR(ES)

Turk, Dennis C

FONTE

BioMed Central

RESUMO

A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted.

Documentos Relacionados

• Should Zelen pre-randomised consent designs be used in some neonatal trials?
• What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?
• Weight-modification trials in older adults: what should the outcome measure be?
• Managing chronic pain in children and adolescents: Procedural sedation should be considered
• Compulsory registration of clinical trials: Maybe European research should be protected